Jan Davidson‐Moncada

1.8k total citations
49 papers, 518 citations indexed

About

Jan Davidson‐Moncada is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Jan Davidson‐Moncada has authored 49 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 26 papers in Immunology and 17 papers in Hematology. Recurrent topics in Jan Davidson‐Moncada's work include CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (16 papers) and Acute Myeloid Leukemia Research (13 papers). Jan Davidson‐Moncada is often cited by papers focused on CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (16 papers) and Acute Myeloid Leukemia Research (13 papers). Jan Davidson‐Moncada collaborates with scholars based in United States, United Kingdom and France. Jan Davidson‐Moncada's co-authors include Wayne Tam, F. Nina Papavasiliou, Richard Childs, Cynthia E. Dunbar, Noriko Sato, Lodewijk V. Dekker, Sergio Rutella, Peter L. Choyke, Guillermo López‐Lluch and Kate Stringaris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jan Davidson‐Moncada

46 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Davidson‐Moncada United States 12 228 215 161 117 89 49 518
Philippe De La Rochère France 6 206 0.9× 202 0.9× 149 0.9× 77 0.7× 76 0.9× 7 478
Stephen Reeder United Kingdom 10 166 0.7× 136 0.6× 123 0.8× 120 1.0× 54 0.6× 21 421
Haizhou Xing China 11 208 0.9× 180 0.8× 192 1.2× 81 0.7× 162 1.8× 31 561
Jayakumar Vadakekolathu United Kingdom 16 218 1.0× 207 1.0× 263 1.6× 116 1.0× 170 1.9× 52 602
Arnika Kathleen Wagner Sweden 13 236 1.0× 337 1.6× 239 1.5× 62 0.5× 122 1.4× 43 688
Jovian Yu United States 11 232 1.0× 216 1.0× 173 1.1× 61 0.5× 43 0.5× 25 506
Todd J. Waldron United States 10 217 1.0× 210 1.0× 240 1.5× 73 0.6× 92 1.0× 11 572
Géraldine Lescaille France 13 242 1.1× 226 1.1× 252 1.6× 52 0.4× 22 0.2× 45 589
Betty Li United States 13 447 2.0× 512 2.4× 186 1.2× 43 0.4× 56 0.6× 30 755
Hannelien Verbeke Belgium 9 234 1.0× 188 0.9× 126 0.8× 62 0.5× 24 0.3× 9 424

Countries citing papers authored by Jan Davidson‐Moncada

Since Specialization
Citations

This map shows the geographic impact of Jan Davidson‐Moncada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Davidson‐Moncada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Davidson‐Moncada more than expected).

Fields of papers citing papers by Jan Davidson‐Moncada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Davidson‐Moncada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Davidson‐Moncada. The network helps show where Jan Davidson‐Moncada may publish in the future.

Co-authorship network of co-authors of Jan Davidson‐Moncada

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Davidson‐Moncada. A scholar is included among the top collaborators of Jan Davidson‐Moncada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Davidson‐Moncada. Jan Davidson‐Moncada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghobadi, Armin, Ibrahim Aldoss, Shannon L. Maude, et al.. (2024). Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL). Transplantation and Cellular Therapy. 30(2). S14–S15. 1 indexed citations
2.
Vadakekolathu, Jayakumar, Laura Arthur, Melissa Tran, et al.. (2024). W-NK1 Choreographs Innate and Adaptive Immune Responses to Provide a Robust and Durable Anti-AML Response. Blood. 144(Supplement 1). 916–916. 3 indexed citations
3.
Kramer, Michael H., Neha Mehta–Shah, Michael P. Rettig, et al.. (2024). Phase 1 Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients with CD7+ T-Cell Non-Hodgkin Lymphoma. Blood. 144(Supplement 1). 2066–2066. 1 indexed citations
4.
Rutella, Sergio, Amanda F. Cashen, John Muth, et al.. (2023). S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML). HemaSphere. 7(S3). e4299744–e4299744. 1 indexed citations
5.
Muz, Barbara, Xiaohua Li, Gregory S. Watson, et al.. (2023). Abstract 6418: xWU-NK-101 as salvage therapy post immune checkpoint blockade (ICB). Cancer Research. 83(7_Supplement). 6418–6418.
6.
Rutella, Sergio, John Muth, Jayakumar Vadakekolathu, et al.. (2023). WU-NK-101 (W-NK), a Memory-like (ML) NK Cell, Intrinsically Overcomes Factors Restricting Adoptive Cell Therapy (ACT) in Acute Myeloid Leukemia (AML). Blood. 142(Supplement 1). 466–466. 1 indexed citations
7.
Barwe, Sonali P., Anne Kisielewski, Ezio Bonvini, et al.. (2022). Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia. Journal of Clinical Medicine. 11(5). 1333–1333. 4 indexed citations
8.
Davidson‐Moncada, Jan, et al.. (2022). 11P WU-NK-101: An enhanced NK cell therapy optimized for function in the tumor microenvironment (TME). Annals of Oncology. 33. S549–S550. 3 indexed citations
9.
Sato, Noriko, Kate Stringaris, Jan Davidson‐Moncada, et al.. (2020). In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging. Clinical Cancer Research. 26(11). 2573–2581. 51 indexed citations
10.
Catenacci, Daniel V.T., Kian‐Huat Lim, Hope E. Uronis, et al.. (2019). Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC).. Journal of Clinical Oncology. 37(4_suppl). 65–65. 16 indexed citations
11.
12.
Gopalakrishnapillai, Anilkumar, Anne Kisielewski, Ezio Bonvini, et al.. (2019). Effect of Ara-C on T-Cell Function and Flotetuzumab Activity in Pediatric Acute Myeloid Leukemia. Blood. 134(Supplement_1). 1387–1387. 1 indexed citations
13.
Wu, Chuanfeng, Diego A. Espinoza, Samson Koelle, et al.. (2018). Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets. Science Immunology. 3(29). 36 indexed citations
14.
15.
Vey, Norbert, Jan Davidson‐Moncada, Geoffrey L. Uy, et al.. (2017). Interim results from a phase 1 first-in-human study of flotetuzumab, a CD123 x CD3 bispecific DART molecule, in AML/MDS. Annals of Oncology. 28. v355–v355. 5 indexed citations
16.
Vey, Norbert, Jan Davidson‐Moncada, Geoffrey L. Uy, et al.. (2017). A phase I, first-in-human study of MGD006/S80880 (CD123 x CD3 DART) in AML/MDS.. Journal of Clinical Oncology. 35(15_suppl). TPS7070–TPS7070. 6 indexed citations
17.
Catenacci, Daniel V.T., Philip J. Gold, Philip Agop Philip, et al.. (2017). A phase 1b/2, open label, dose-escalation study of margetuximab (M) in combination with pembrolizumab (P) in patients with relapsed/refractory advanced HER2+ gastroesophageal (GEJ) junction or gastric (G) cancer.. Journal of Clinical Oncology. 35(4_suppl). TPS219–TPS219. 10 indexed citations
18.
19.
Davidson‐Moncada, Jan, F. Nina Papavasiliou, & Wayne Tam. (2010). MicroRNAs of the immune system. Annals of the New York Academy of Sciences. 1183(1). 183–194. 143 indexed citations
20.
Davidson‐Moncada, Jan, Guillermo López‐Lluch, Anthony W. Segal, & Lodewijk V. Dekker. (2002). Involvement of protein kinase D in Fcγ-receptor activation of the NADPH oxidase in neutrophils. Biochemical Journal. 363(1). 95–95. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe De La Rochère Breakdown of academic impact, for papers by Stephen Reeder Breakdown of academic impact, for papers by Haizhou Xing Breakdown of academic impact, for papers by Jayakumar Vadakekolathu Breakdown of academic impact, for papers by Arnika Kathleen Wagner Breakdown of academic impact, for papers by Jovian Yu Breakdown of academic impact, for papers by Todd J. Waldron Breakdown of academic impact, for papers by Géraldine Lescaille Breakdown of academic impact, for papers by Betty Li Breakdown of academic impact, for papers by Hannelien Verbeke
Rankless by CCL
2026